Passage bio's share price could stay at $31.50 by jul 1, 2022. Pasg passage bio inc — stock price and discussion | stocktwits.
Pasg) fell 13.19% on friday january 22 from a previous close of $22.82 to $19.81.
Passage bio stock price. Investors are responding to the company announcing a public offering. Get the latest passage bio, inc. Pasg has a market cap of $676mn and a cash reserve of $437mn, so the market is putting a pretty low price on their pipeline right now.
The average passage bio stock price prediction forecasts a potential downside of n/a from the current pasg share price of $7.51. Passage bio inc nasdaq updated nov 26, 2021 6:01 pm. The average price target is $27.03, with a high forecast of $45.00 and a low forecast of $2.21.
Genetic medicines company passage bio to offer 7.4 million shares in ipo priced at $16 to $18 each marketwatch. The company made a $125mn offering as well as. On thursday evening, passage bio had announced the pricing of its underwritten public offering of 7 million shares of its.
P assage bio, a preclinical biotech developing gene therapies for rare cns disorders, raised $216 million by offering an upsized 12 million. Passage bio started at overweight with $25 stock price target at j.p. According to the issued ratings of 8 analysts in the last year, the consensus rating for passage bio stock is buy based on the current 1 hold rating and 7 buy ratings for pasg.
Compare pasg stock to peers. Get the latest passage bio stock price and detailed information including pasg news, historical charts and realtime prices. Investorsobserver gives passage bio inc (pasg) an overall rank of 47, which is below average.
View daily, weekly or monthly format back to when passage bio, inc. Passage bio shares were trading higher after goldman sachs upgraded the stock from neutral to buy and raised its price target from $28 to $30. Passage bio (nasdaq:pasg) picked a difficult week to make its public debut,.
The average price target represents a 232.83% upside from the last price of $8.12. Passage bio inc is in the bottom half of stocks based on the fundamental outlook for the stock and an analysis of the stock's chart. Passage bio sets ipo terms, to offer 7.4 mln shares priced at $16 to $18 each marketwatch.
Passage bio started at outperform with $26 stock price target at wedbush. The stock price of genetic medicines company passage bio inc (nasdaq: 102 rows discover historical prices for pasg stock on yahoo finance.
This price target is based on 8 analysts offering 12 month price targets for passage bio in the last 3 months. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. A rank of 47 means that 53% of stocks appear more favorable to our system.
On average, wall street analysts predict that. 25, 2021 at 7:22 a.m. The closing price, intraday high, intraday low and volume have been adjusted to account for any stock splits and/or dividends that may have occurred for this security since the date shown above.
Learn more on pasg's analyst rating history Stock advisor list price is $199 per year.
